Competitive and technological changes, from powerful new drug chemistries to innovative R&D partnerships, are reshaping the business strategies of pharmaceutical and biotechnology companies.
ARCADIS helps these companies thrive in an evolving marketplace by offering a comprehensive portfolio of environmental, water, health and safety services. The ARCADIS environmental portfolio, aligned specifically for the pharmaceutical and biotechnology industries, includes:
- Industrial hygiene services
- Toxicity evaluation/testing
- R&D/clean room facilities
- Chemical inventory management services
Local and international expertise
Our international staff of toxicologists, analysts and scientists is highly experienced with due diligence services and local regulations and customs.
For example, our product stewardship and chemicals regulation teams are ready to advise on REACH, CLP and similar regulations in force in Europe, Asia and North America. ARCADIS also has gained significant nanotechnology expertise, including product use/disposal methods and required U.S. FDA environmental assessments.
Facilities and property management
Outside the laboratory, our teams of accomplished engineers are ready to support the needs of pharmaceutical clients with a strong set of facilities, infrastructure and water services, including:
- Site remediation and redevelopment
- Facility infrastructure design
- Deactivation, decommissioning, decontamination and demolition (D4)
- Water/industrial wastewater treatment
- Industrial wastewater retrofits for plant upgrades
Our multidisciplinary expertise in environmental science gives the
pharmaceutical industry a trusted partner to profitably pursue
tomorrow's opportunities today.